
These are articles that I have published in the medical literature.
Resolution of anxiety, binge eating, insomnia, vasomotor symptoms, and laryngopharyngeal reflux with a carnivore ketogenic diet: Case report interpreted through the lens of energy resistance

This retrospective case report details the resolution of symptoms of lifelong anxiety, panic attacks, binge eating disorder, menopausal vasomotor symptoms, and laryngopharyngeal reflux in a 48-year-old female contemplative scientist. It explores how interventions targeting systemic energy metabolism, consistent with the Energy Resistance Principle and mitochondrial dysfunction, could target the hallmarks of disease. Interventions, including a carnivore ketogenic diet and other lifestyle strategies, are suggested to have improved energy transformation, leading to improvements in symptoms. It is notable that the dietary change resulted in a lean mass hyper-responder lipid profile phenotype, which aligns with an increased reliance on fat metabolism. Compliance with diet is reported using glucose and ketone blood testing, and the qualitative impact is explored from the subject’s perspective. Click here to read the full article.
Case Report: Remission of schizophrenia using a carnivore ketogenic metabolic therapy
This retrospective case report presents the use of a carnivore ketogenic diet by a subject with schizophrenia, supported by a nutritional therapy practitioner, resulting in remission. The narrative describes how ketogenic metabolic therapy can be implemented and optimized in difficult socio-economic circumstances, something not previously reported in the literature. Compliance with diet is reported using glucose and ketone blood markers. The qualitative impact of the therapy is explored from the subject's perspective as well as the potential for collaboration between nutritional and mental health practitioners to help implement and sustain ketogenic therapies. Click here to read the full article.
Digital-first approach to Long COVID management: feasibility and efficacy of the Avid health programme.
An evaluation of the effectiveness of a new human-centred, digital-first health platform - Avid - for the management of long COVID by examining its impact on participants quality of life scores and symptom severity in the short-term, and the platform’s usability and acceptability for end-users. The pilot study indicates that the Avid platform is safe, feasible and effective. It produced significant and sustained improvements in the symptoms and severity of long COVID, and wider measures of quality of life in the short-term. Click here to read the full article.


